New Cerebral Microbleeds After Catheter‐Based Structural Heart Interventions: An Exploratory Analysis

Autor: Tim Bastian Braemswig, Madeleine Kusserow, Barbara Bellmann, Frederik Beckhoff, Markus Reinthaler, Regina von Rennenberg, Hebun Erdur, Jan F. Scheitz, Ivana Galinovic, Kersten Villringer, David M. Leistner, Heinrich J. Audebert, Matthias Endres, Ulf Landmesser, Karl Georg Haeusler, Jochen B. Fiebach, Alexander Lauten, Andreas Rillig, Christian H. Nolte

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 3 (2023)

Background Cerebral microbleeds (CMBs) are increasingly recognized as “covert” brain lesions indicating increased risk of future neurological events. However, data on CMBs in patients undergoing catheter‐based structural heart interventions are

Externí odkaz: https://doaj.org/article/8894332c1eb544ddbfef5d486e3e3365

Early New Ischemic Lesions Located Outside the Initially Affected Vascular Territory Appear More Often in Stroke Patients with Elevated Glycated Hemoglobin (HbA1c)

Autor: Tim Bastian Braemswig, Christian H. Nolte, Jochen B. Fiebach, Tatiana Usnich

Publikováno v: Frontiers in Neurology, Vol 8 (2017)

BackgroundEarly new ischemic lesions are common in patients with an acute ischemic stroke. These new ischemic lesions may represent the natural course of the initial stroke or de novo events.ObjectiveWe hypothesized that early new ischemic lesions lo

Externí odkaz: https://doaj.org/article/69499484f98f4f7b91ff9b5492e900ec

Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke:An Analysis of the WAKE-UP Randomized Clinical Trial

Autor: Norbert Nighoghossian, Jan Vynckier, Josep Puig, Vincent Thijs, Claus Z Simonsen, Tim Bastian Braemswig, Götz Thomalla, Märit Jensen, Florent Boutitie, Ivana Galinovic, Christian H. Nolte, Christian Gerloff, Bastian Cheng, Martin Ebinger, Keith W. Muir, Jens Fiehler, Salvador Pedraza, Robin Lemmens, Matthias Endres, Jochen B. Fiebach, Ludwig Schlemm, Wake-Up investigators, Tae-Hee Cho

Publikováno v: Schlemm, L, Braemswig, T B, Boutitie, F, Vynckier, J, Jensen, M, Galinovic, I, Simonsen, C Z, Cheng, B, Cho, T H, Fiehler, J, Puig, J, Thijs, V, Fiebach, J, Muir, K, Nighoghossian, N, Ebinger, M, Pedraza, S, Thomalla, G, Gerloff, C, Endres, M, Lemmens, R, Nolte, C H & WAKE-UP investigators 2022, ' Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke : An Analysis of the WAKE-UP Randomized Clinical Trial ', Neurology, vol. 98, no. 3, pp. E302-E314 . https://doi.org/10.1212/WNL.0000000000013055
Neurology 98(3), e302-e314 (2022). doi:10.1212/WNL.0000000000013055
Neurology
Neurology, 2021, ⟨10.1212/wnl.0000000000013055⟩

Background and ObjectivesCerebral microbleeds (CMBs) are common in patients with acute ischemic stroke and are associated with increased risk of intracerebral hemorrhage (ICH) after intravenous thrombolysis. Whether CMBs modify the treatment effect o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b268c3ea898b04f185977bef624c95a1
https://pure.au.dk/portal/da/publications/cerebral-microbleeds-and-treatment-effect-of-intravenous-thrombolysis-in-acute-stroke(b681d948-591c-4ebe-9b50-b220178dd847).html

Predictors of new remote cerebral microbleeds after IV thrombolysis for ischemic stroke

Autor: Hebun Erdur, Christian H. Nolte, Jochen B. Fiebach, Heinrich J. Audebert, Tim Bastian Braemswig, Guillaume Turc, Jan F. Scheitz, Matthias Endres, Kersten Villringer

Publikováno v: Neurology 92(7), e630-e638 (2019). doi:10.1212/WNL.0000000000006915

ObjectiveTo assess the frequency, associated factors, and underlying vasculopathy of new remote cerebral microbleeds (CMB), as well as the risk of concomitant hemorrhagic complications related to new CMBs, after IV thrombolysis (IVT) in acute stroke

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bdcb98a7fffed1ec04fd71f5ce44df6
https://pubmed.ncbi.nlm.nih.gov/30674598

Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab

Autor: Christian H. Nolte, Christoph C. Eschenfelder, Tim Bastian Braemswig

Publikováno v: The American journal of emergency medicine. 35(4)

Idarucizumab is an antibody fragment which is used to reverse the anticoagulant effects of dabigatran. We report on the first successful use of idarucizumab before performing an emergency lumbar puncture in a patient on effective anticoagulation with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0c9fcf88f7b862243225ddf43cb44b
https://pubmed.ncbi.nlm.nih.gov/27836320